Tag: #sicklecell

Articles related to sicklecell

health

UK regulator extends Casgevy gene‑editing therapy to children aged 5 and over

MHRA has extended Casgevy (exa‑cel) approval to children aged 5+, widening access to CRISPR stem‑cell therapy for severe sickle‑cell disease and β‑thalassemia.

$VRTX, #health, #geneediting, #sicklecell, #vertex

health

FDA expands Casgevy gene therapy to children as young as 2 for sickle cell and beta-thalassemia

FDA clears Vertex’s Casgevy for children aged 2+ with sickle cell disease or transfusion-dependent beta-thalassemia, widening access to a one-time gene therapy.

$VRTX, #sicklecell, #gene-therapy, #casgevy, #vertex, #fda